Connexin 43 and Pannexin 1 in Renal Cell Populations in Diabetic Kidney Disease
Authors:
- Marinela Jelinčić KorčulaninMKMarinela Jelinčić Korčulanin
- Anita RacetinARAnita Racetin
- Nikola PavlovićNPNikola Pavlović
- Ivo JeličićIJIvo Jeličić
- Merica Glavina DurdovMDMerica Glavina Durdov
- Monika AndrzejewskaMAMonika Andrzejewska
- Leo JerčićLJLeo Jerčić
- Ivana BočinaIBIvana Bočina
- Nives KevićNives Kević
- Ivana RestovićIRIvana Restović
- Katarina VukojevićKatarina Vukojević
- Patricija BajtPBPatricija Bajt
Open Access
- 25 February 2026
- journal article
- research article
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 27 (5) , 2152
Abstract
We studied the expression of connexin 43 (Cx43) and pannexin 1 (PANX1) in different cellular populations of the kidneys of diabetic mice and diabetic and non-diabetic patients, to evaluate their role as potential therapeutic targets in diabetic kidney disease (DKD). A combination of a low dose of streptozotocin and a high-fat diet (HFD) was used to induce a type 2 diabetes model (DM2) in mice. Kidney tissues from diabetic (n = 9) and control patients (n = 11) who underwent nephrectomy were collected. Tissues from mice and humans were processed for double immunofluorescence, using antibodies against Cx43, phosphorylated Cx43 (pCx43) or PANX1 and markers for specific cell populations: endothelium (CD31/PECAM1); pericytes/mesangium (PDGFRB); podocytes (nephrin/synaptopodin); proximal tubules and collecting ducts (aquaporin 2). The results showed a significant decrease in the expression of pCx43 in PDGFRB-immunoreactive mesangium in diabetic patients compared to the control group (p < 0.0001). This contrasted with an increase in pCx43 in pericytes of diabetic mice (p = 0.1). However, we found a general decrease in Cx43 protein expression in diabetic mouse kidneys (p < 0.05). We also found a decrease in the expression of PANX1 in endothelial cells of diabetic patients (p < 0.05) and a significant increase in PANX1 expression in cells expressing PDGFRB (p < 0.05). Expression of PANX1 in endothelium (r = −0.50; p < 0.05) and pCx43 in the mesangium (r = −0.65; p < 0.01) correlated negatively with the percentage of sclerotic glomeruli. The expression and activation of Cx43 and the expression of PANX1 are altered in distinct populations of renal cells during long-term type 2 diabetes mellitus, especially cells of the vascular wall. This may indicate their role in the pathophysiological processes of DKD. Therefore, connexin and pannexin channels could be considered as possible therapeutic targets in the prevention and treatment of diabetic kidney disease.Keywords
Funding Information
- Hrvatska Zaklada za Znanost (HRZZ-IP-2022-10-7321)
This publication has 62 references indexed in Scilit:
- TGF-β signaling in health and diseaseCell, 2023
- Sex-specific effects of metformin and liraglutide on renal pathology and expression of connexin 45 and pannexin 1 following long-term high-fat high-sugar dietActa Histochemica, 2021
- USP9X deubiquitinates connexin43 to prevent high glucose-induced epithelial-to-mesenchymal transition in NRK-52E cellsBiochemical Pharmacology, 2021
- Elevation of JAML Promotes Diabetic Kidney Disease by Modulating Podocyte Lipid MetabolismCell Metabolism, 2020
- Examining Local Cell-to-Cell Signalling in the Kidney Using ATP Biosensing2020
- PUFAs supplementation affects the renal expression of pannexin 1 and connexins in diabetic kidney of ratsHistochemistry and Cell Biology, 2019
- Dietary DHA/EPA supplementation ameliorates diabetic nephropathy by protecting from distal tubular cell damageCell and tissue research, 2019
- Astaxanthin ameliorates experimental diabetes-induced renal oxidative stress and fibronectin by upregulating connexin43 in glomerular mesangial cells and diabetic miceEuropean Journal of Pharmacology, 2018
- Reabsorption in the proximal tubuli—ultrastructural evidence for a novel aspect of renal VEGF traffickingCell and tissue research, 2018
- Altered gap junctional communication and renal haemodynamics in Zucker fatty rat model of type 2 diabetesDiabetologia, 2011